TCL Archive As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data. October 22, 2004
TCL Archive Senate Committee Directs NCI To Conduct Research To Eliminate Barriers To Enrollment On Clinical Trials. July 6, 2007
TCL Archive Letters to the Editor: Burzynski: Reviewers Sought To Discredit Antineoplaston Therapy October 30, 1998
TCL Archive Facility Needs Panel Recommends $4.5-3 billion, Seven Year Program To Be Run By NIGMS Or DRR March 4, 1988
